| Triple-negative breast cancer WD Foulkes, IE Smith, JS Reis-Filho New England journal of medicine 363 (20), 1938-1948, 2010 | 4627 | 2010 |
| REVEL: an ensemble method for predicting the pathogenicity of rare missense variants NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ... The American Journal of Human Genetics 99 (4), 877-885, 2016 | 1846 | 2016 |
| BRCA1 and BRCA2: 1994 and beyond SA Narod, WD Foulkes Nature Reviews Cancer 4 (9), 665-676, 2004 | 1313 | 2004 |
| Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer WD Foulkes, IM Stefansson, PO Chappuis, LR Bégin, JR Goffin, N Wong, ... Journal of the national cancer institute 95 (19), 1482-1485, 2003 | 1307 | 2003 |
| Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 … FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ... PLoS medicine 7 (5), e1000279, 2010 | 1255 | 2010 |
| Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014 | 1080 | 2014 |
| Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015 | 1019 | 2015 |
| Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results SE Plon, DM Eccles, D Easton, WD Foulkes, M Genuardi, MS Greenblatt, ... Human mutation 29 (11), 1282-1291, 2008 | 1009 | 2008 |
| Familial adenomatous polyposis P Galiatsatos, WD Foulkes Official journal of the American College of Gastroenterology| ACG 101 (2 …, 2006 | 924 | 2006 |
| Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation A Finch, M Beiner, J Lubinski, HT Lynch, P Moller, B Rosen, J Murphy, ... Jama 296 (2), 185-192, 2006 | 803 | 2006 |
| Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers K Metcalfe, HT Lynch, P Ghadirian, N Tung, I Olivotto, E Warner, ... Journal of Clinical Oncology 22 (12), 2328-2335, 2004 | 774 | 2004 |
| Is breast cancer the same disease in Asian and Western countries? SPL Leong, ZZ Shen, TJ Liu, G Agarwal, T Tajima, NS Paik, K Sandelin, ... World journal of surgery 34, 2308-2324, 2010 | 747 | 2010 |
| Inherited susceptibility to common cancers WD Foulkes New England Journal of Medicine 359 (20), 2143-2153, 2008 | 745 | 2008 |
| Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation APM Finch, J Lubinski, P Møller, CF Singer, B Karlan, L Senter, B Rosen, ... Journal of Clinical Oncology 32 (15), 1547, 2014 | 719 | 2014 |
| Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes EA Rakha, SE Elsheikh, MA Aleskandarany, HO Habashi, AR Green, ... Clinical Cancer Research 15 (7), 2302-2310, 2009 | 663 | 2009 |
| Folate-binding protein is a marker for ovarian cancer IG Campbell, TA Jones, WD Foulkes, J Trowsdale Cancer research 51 (19), 5329-5338, 1991 | 639 | 1991 |
| Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7, 1-11, 2007 | 564 | 2007 |
| Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study A Eisen, J Lubinski, J Klijn, P Moller, HT Lynch, K Offit, B Weber, ... Journal of clinical oncology 23 (30), 7491-7496, 2005 | 558 | 2005 |
| Triple-negative breast cancer: risk factors to potential targets BP Schneider, EP Winer, WD Foulkes, J Garber, CM Perou, A Richardson, ... Clinical Cancer Research 14 (24), 8010-8018, 2008 | 545 | 2008 |
| Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study KM O'Brien, SR Cole, CK Tse, CM Perou, LA Carey, WD Foulkes, ... Clinical Cancer Research 16 (24), 6100-6110, 2010 | 538 | 2010 |
